Department of Medicine Archives
A new target for lung cancer
Aug. 17, 2018—Xiangming Ji, Pierre Massion and colleagues have discovered that blocking the transporter protein xCT could slow the progression of non-small cell lung cancer.
Vanderbilt study links gene expression, disease association data
Jul. 27, 2018—An international team of researchers led by Eric Gamazon has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.
Grant to develop method of measuring medical trust in African American men
Jul. 20, 2018—Vanderbilt researchers have received a two-year, $250,000 grant from the Robert Wood Johnson Foundation to develop a new way to measure trust in African American men as it relates to health care.
Novel insights on “leaky” gut
Jul. 20, 2018—Disruption of the integrity of the intestinal lining or epithelium contributes to a “leaky” gut and is a common feature of patients with inflammatory bowel disease. Yash Choksi, Christopher Williams and colleagues found that low levels of a certain protein exacerbated the condition.
Ikizler to succeed Harris as Nephrology and Hypertension director
Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.
Roden’s circulatory diseases research honored
Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
Shared genetics may shape treatment options for certain brain disorders
Jun. 14, 2018—Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting.
VUMC joins research network to fight atrial fibrillation
Jun. 14, 2018—Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.
State of the Department of Medicine address reviews achievement, challenges
Jun. 14, 2018—Nancy Brown, M.D., Hugh J. Morgan Professor and chair of the Department of Medicine in the Vanderbilt University School of Medicine, delivered a mixture of accolades and challenges to the dozens of faculty members, residents and fellows who attended her annual State of the Department address last week in Langford Auditorium.
Confronting TB resistance
Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
How providers receive feedback plays crucial role in antimicrobial stewardship programs
Jun. 7, 2018—Antimicrobial resistance continues to increase, and antimicrobial stewardship programs are developing plans to report antimicrobial use in order to reduce and optimize the use of antibiotics.
Enzyme protects against obesity-related heart disease
Jun. 7, 2018—Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.